How Flagship's Valo is reshaping AI drug discovery with human data

Theialife’s race to bring a childhood myopia treatment to market

The best biotech conversations you missed this summer

Rewriting the rules of genetic medicine with tRNA therapeutics

How Evox Therapeutics is targeting CNS diseases with exosomes

BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech

Beyond biology: Nanobiotix's physics-first approach to cancer

How Cancer Research Horizons is building the future of childhood cancer medicines

Why Western pharma is sleeping on China's circular RNA revolution

Gain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson's

This nonprofit is building the ecosystem to cure epidermolysis bullosa

How BIO-Europe is expanding beyond dealmaking in 2026

Turning cancer cell dependencies into targeted therapies

The first PROTAC is here. What comes next in protein degradation?

De-risking neurology drug development with better mouse models

BIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler

Advancing corticosteroids and hormonal therapies for supply and scale

Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media

World MS Day Special: Immunic reveals new hope for progressive MS

The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data

Freeze variability, not progress: strengthen your cell therapy supply chain from the start

Making labs smarter for scientific breakthroughs

How Epicrispr is leveraging CRISPR without cutting DNA

Diagonal Therapeutics’ innovative clustering antibodies for vascular diseases

Argobio: the venture model building Europe’s next biotech champions

Multi-agent AI delivers reliable and scalable insights for single-cell omics

Nionyx Bio's kidney gene therapy wins the 2026 BIO-Europe Spring Startup Spotlight

HaemaLogiX - precision immunotherapy for multiple myeloma

How Leyden Labs is revolutionizing flu protection with its intranasal antibody spray

How to optimize your biotech company for partnering, licensing, and business success

Reversing tumor immunosuppression with next-gen GPCR modulation

Misinformation is a public health crisis - here's how to fix it

Accelerating rare disease cures with ASOs, gene editing, and AI

Using AI to crack undruggable drug targets

How Eli Lilly's biotech collaboration model is rewriting early-stage innovation

Building a smart oncology pipeline with Cumulus Oncology

Top 5 trends that will drive biopharma in the next decade with Tim Opler

Labiotech's 15 biopharma companies to watch in 2026

M Ventures: pharma CVC and biotech innovation in 2026

Johnson & Johnson’s hematology portfolio: breakthroughs to watch

Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach

Cracking Cancer’s Code: Transforming Research with Novel Cancer Models

Curing cancer: Daiichi Sankyo's ambitious ADC approach

How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes

Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology

Next‑generation UTI diagnostics: delivering results in just 35 minutes

How AI Is revolutionizing synthetic biology and biomanufacturing

Pichia pastoris: the microbial protein expression platform you’re probably underestimating

Biotech royalty deals on the rise and here to stay

Contraline's ADAM in the clinic: towards a new era of male contraception?

Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play

What’s next in immunology & inflammation R&D: The trends to watch

BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year

AION Labs is building innovative biotechs with top pharma partners in Israel

Navigating the biotech development journey from first steps to global scale with Lonza

A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox ...

How RNAi is expanding from a therapy of choice for rare disease into treating common conditions

Are next-generation psychedelics the way forward for addressing treatment resistant depression?

Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn

Meatly's innovative cultivated meat is already delighting pets, are humans next?